TNFRSF10A and neoplasm: The observation by Wang et al. that tumors from a portion of patients with NPC express TRAIL-R1 (29.9%) and TRAIL-R2 (36.6%) and that the expression of TRAIL-R2 was associated with a better survival rate, indicates that the TRAIL-signaling pathway is of importance in the elimination of NPC tumor cells [28].